{"id":"W2309217041","doi":"","title":"Infliximab use in patients with Crohn's disease: quality of life, costs and resource use.","year":2006,"lang":"en","type":"article","venue":"PubMed","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Infliximab; Crohn's disease; Incidence (geometry); Quality of life (healthcare); Internal medicine; Disease; Maintenance therapy; Surgery; Inflammatory bowel disease; Refractory (planetary science); Gastroenterology; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007828186,0.0002745664,0.0004930781,0.001534677,0.0003137172,0.001235898,0.0002686593,0.0006944448,0.003479125],"category_scores_gemma":[0.004046974,0.0001350319,0.000866776,0.004099417,0.0002043866,0.0007325303,0.0005265135,0.0009102468,0.0004986678],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001358873,"about_ca_system_score_gemma":0.0005511495,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006585194,"about_ca_topic_score_gemma":0.00812851,"domain_scores_codex":[0.9989084,0.0003753324,0.0001923532,0.00006275043,0.0003524093,0.0001088487],"domain_scores_gemma":[0.9977342,0.0003100598,0.001319718,0.00002755219,0.000240446,0.0003678836],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005232697,0.0002007257,0.9410759,0.0007277835,0.0005789127,0.0002890433,0.0001707272,0.0002737531,0.00009167578,0.0001766711,0.004547188,0.05134432],"study_design_scores_gemma":[0.00002646965,0.0001966502,0.9941522,0.0003155256,0.0001983201,0.0006802321,0.0003707423,0.0004850915,0.00002104426,0.0001391499,0.003399212,0.0000153907],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7905387,0.1700719,0.0002970707,0.01043704,0.0003303787,0.0001144989,0.01225776,0.00002750569,0.01592505],"genre_scores_gemma":[0.9745384,0.02051375,0.0003297512,0.0008277557,0.0001817106,0.0000624829,0.002745043,0.000006393021,0.0007947099],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006585194,"threshold_uncertainty_score":0.01309371,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009610371515404071,"score_gpt":0.1997192462695699,"score_spread":0.1901088747541658,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}